Enpatoran,2101938-42-3

MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Enpatoran

CAS No. : 2101938-42-3

MCE 国际站：Enpatoran

产品活性：Enpatoran (M5049) 是一种有效的、具有口服活性的 TLR7/8 抑制剂，在HEK293 细胞中，其IC₅₀s 分别为 11.1 nM 和 24.1 nM。Enpatoran 对 TLR3, TLR4 和 TLR9 无活性。Enpatoran 可以阻断分子合成配体和天然内源性 RNA 配体。Enpatoran 在体内的表现出良好的药代动力学特性。Enpatoran 可用于先天性和适应性自身免疫阻断的相关研究。

研究领域：Immunology/Inflammation

作用靶点：Toll-like Receptor (TLR)

In Vitro: Enpatoran (0.01 nM-10 μM) inhibits production of IL-6 stimulated by all the ligands (miR-122, Let7c RNA, Alu RNA, and R848) with IC₅₀ values ranging from 35 to 45 nM.

In Vivo: Pre-treatment with Enpatoran (M5049; oral gavage; 1 mg/kg) before R848 (intraperitoneal injection of 25 μg) dose-dependently inhibits the production of IL-6 and IFN-α in mice.
?Enpatoran (M5049) exhibits high oral bioavailability (mouse 100%, rat 87%, dog 84%) following oral administration (mouse, rat and dog 1.0 mg/kg).
?Enpatoran exhibits moderate half-lives (mouse 1.4, rat 5.0 and dog 13 h) due to high plasma clearance (1.4, 1.2 and 0.59 L/h/kg, respectively) combined with large volumes of distribution (2.7, 8.7 and 5.7 L/kg, respectively) following intravenous administration (mouse, rat and dog 1.0 mg/kg).

相关产品：Drug Repurposing Compound Library Plus  |  Clinical Compound Library Plus  |  Bioactive Compound Library Plus  |  Chloroquine  |  Lipopolysaccharides  |  Resatorvid  |  Resiquimod  |  Polyinosinic-polycytidylic acid  |  C29  |  Imiquimod  |  Hydroxychloroquine sulfate  |  Pam3CSK4 TFA  |  Sulfo-ara-F-NMN  |  CU-CPT 4a  |  ODN 1826  |  Agatolimod  |  Telratolimod  |  Vesatolimod  |  TLR4-IN-C34  |  CU-CPT22  |  Motolimod  |  Diprovocim  |  AT791  |  Complete Freund's adjuvant (CFA)  |  ABR-238901  |  CU-T12-9  |  Selgantolimod  |  TH1020  |  ODN 1018

热门产品线：重组蛋白  |  化合物库  |  天然产物  |  荧光染料  |  PROTAC  |  同位素标记物

Trending products：Recombinant Proteins  |  Bioactive Screening Libraries  |  Natural Products  |  Dye Reagents  |  PROTAC  |  Isotope-Labeled Compounds